Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Some pediatric Ewing's sarcoma patients may experience permanent hair loss after chemotherapy, and treatments might not fully restore hair.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Baricitinib was effective in treating both early and late onset alopecia areata.

Blocking Sonic Hedgehog signaling may help manage hair loss from chemotherapy.

Burn reconstruction is crucial for improving long-term outcomes for burn survivors.

Hair loss from chemotherapy causes significant distress and affects social roles for ovarian and uterine cancer patients.

Cancer patients in sub-Saharan Africa face significant challenges during chemotherapy, highlighting the need for better patient care and support.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Young cancer survivors need better information on wigs and hair regrowth.

Mesotherapy with dutasteride effectively treats hair loss with manageable side effects.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Mesotherapy involves injecting substances like dutasteride, minoxidil, and vitamins into the skin to treat hair loss and skin conditions, with good patient satisfaction but possible skin inflammation.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Finasteride can prevent breast cancer progression by blocking progesterone's conversion to a cancer-promoting hormone.